We are live on ! Find out more
OMGA

Omega Therapeutics, Inc. Common Stock
OMGA

Delisted

OMGA was delisted on the 24th of February, 2025.

Back to rankings

70 hedge funds and large institutions have $187M invested in Omega Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

23% more capital invested

Capital invested by funds: $152M → $187M (+$35.1M)

11% more funds holding

Funds holding: 63 → 70 (+7)

6% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 16

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

34% less call options, than puts

Call options by funds: $188K | Put options by funds: $287K

Holders
70
Holders Change
+7
Holders Change %
+11.11%
% of All Funds
1.01%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
17
Reduced
16
Closed
11
Calls
$188K
Puts
$287K
Net Calls
-$99K
Net Calls Change
-$41K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.86M
2
Millennium Management
Millennium Management
New York
+$1.15M
3
BCM
Bridgeway Capital Management
Texas
+$552K
4
Marshall Wace
Marshall Wace
United Kingdom
+$228K
5
BlackRock
BlackRock
New York
+$127K

Top Sellers

Rank Fund Capital Flow
1
ZIM
Zacks Investment Management
Illinois
-$922K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$879K
3
Squarepoint
Squarepoint
New York
-$417K
4
Morgan Stanley
Morgan Stanley
New York
-$204K
5
Bank of America
Bank of America
North Carolina
-$143K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$107M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$23M +$3.86M +1,006,582 +19%
HP
3
Harbourvest Partners
Massachusetts
$12.8M – – –
State of Wisconsin Investment Board
4
State of Wisconsin Investment Board
Wisconsin
$6.78M – – –
BlackRock
5
BlackRock
New York
$5.17M +$127K +33,148 +2%
AG
6
Artal Group
Luxembourg
$4.83M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$4.67M -$879K -229,263 -15%
BOCH
8
Blue Owl Capital Holdings
New York
$3.85M – – –
PIM
9
Platinum Investment Management
Australia
$3.24M – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$1.83M +$87.7K +22,866 +5%
State Street
11
State Street
Massachusetts
$1.76M +$116K +30,144 +7%
Citigroup
12
Citigroup
New York
$1.75M +$1.4K +366 +0.1%
7IH
13
72 Investment Holdings
Connecticut
$1.29M – – –
Millennium Management
14
Millennium Management
New York
$1.19M +$1.15M +300,713 +1,138%
SOMRS
15
State of Michigan Retirement System
Michigan
$1.15M – – –
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$1.02M -$72.1K -18,817 -6%
Northern Trust
17
Northern Trust
Illinois
$729K +$9.17K +2,391 +1%
BCM
18
Bridgeway Capital Management
Texas
$526K +$552K +144,000 New
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$472K – – –
Morgan Stanley
20
Morgan Stanley
New York
$469K -$204K -53,171 -29%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$458K -$18.8K -4,899 -4%
6CM
22
683 Capital Management
New York
$420K – – –
RC
23
RBF Capital
California
$242K – – –
Charles Schwab
24
Charles Schwab
California
$238K – – –
N
25
Nuveen
North Carolina
$223K +$58.3K +15,215 +33%
1
2 3 4

OMGA Hedge Fund Activity: Q1 2024 in Review

70 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q1 2024, worth a combined $187M — up 23% from $152M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new OMGA positions and 11 closed out — a net gain of 8 holders — while 17 added to existing stakes and 16 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $3.86M. The largest seller was Zacks Investment Management, exiting entirely with an estimated $922K sold.

  • 70 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q1 2024, up from 63 in Q4 2023.
  • Funds reported $187M of Omega Therapeutics, Inc. Common Stock stock for Q1 2024, up 23% quarter-over-quarter.
  • 19 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q1 2024 and 11 closed out, a net change of +8 holders.
  • The largest Omega Therapeutics, Inc. Common Stock buyer in Q1 2024 was Fidelity Investments, an estimated $3.86M added.
  • The largest Omega Therapeutics, Inc. Common Stock seller in Q1 2024 was Zacks Investment Management, an estimated $922K sold.

Based on aggregated 13F filings for Q1 2024.